North America Pranlukast Market Size & Outlook, 2026-2034


North America Pranlukast Market Insights

  • As highlighted in Reed Intelligence analysis, the North America Pranlukast Market, valued at USD 259.93 Billion in 2025, is estimated to achieve USD 534.33 Billion by 2034.
  • The market is estimated to grow at a CAGR of 8.31% spanning 2026 to 2034.
  • By market size, Tablets led the Formulation Type category in 2025.
  • The Formulation Type segment led by Oral Suspensions is estimated to post the fastest growth, sustaining its position as the most lucrative during the forecast timeframe.

Other Key Findings


  • North America held 35.03% share of the global Pranlukast Market size in 2025.
  • United States is expected to remain the largest contributor to the global market size by 2034.
  • By 2034, United States is anticipated to record the highest growth in North America, with the market size expected to reach USD 395.02 Billion.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 259.93 Billion
Market Size In 2034 USD 534.33 Billion
Largest segment Tablets
Units Revenue in USD Billion
CAGR 8.31% (2026-2034)
Segmnetation Covered
North America
  1. United States
  2. Canada
Formulation Type
  1. Tablets
  2. Capsules
  3. Oral Suspensions
  4. Others
Application
  1. Asthma Treatment
  2. Allergic Rhinitis Treatment
  3. Bronchitis Management
  4. Others
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Drug Stores
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends